SURFACE ONCOLOGY INC (SURF) Forecast, Price Target & Analyst Ratings

Name: SURFACE ONCOLOGY INC (SURF) Analyst Consensus Rating
Brand: SURFACE ONCOLOGY INC
Rating: 7.5 (11 reviews)

NASDAQ:SURF • US86877M2098

1.07 USD

-0.01 (-0.93%)

At close: Sep 7, 2023

1.07 USD

0 (0%)

After Hours: 9/7/2023, 8:23:11 PM

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SURFACE ONCOLOGY INC (SURF).

Consensus Price Target

Price Target

$2.43

+ 127.19% Upside

→ Price target details

Next Earnings Forecast

Earnings Estimate

Release Date: Oct 31, 2023
Period: Q3 / 2023
EPS Estimate: -$0.36
Revenue Estimate

→ Full earnings forecast details

ChartMill Buy Consensus

Rating

76.36%

Weighted Analyst Rating Score

→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target

$2.43

Upside

+ 127.19%

From current price of $1.07 to mean target of $2.43, Based on 11 analyst forecasts

Low

$1.01

Median

$1.17

High

$5.25

Price Target Revisions

1 Month

0.00%

3 Months

-54.60%

Price Target Summary

11 Wall Street analysts provided a forecast for the next 12 months for SURF. The average price target is 2.43 USD. This implies a price increase of 127.19% is expected in the next year compared to the current price of 1.07.

The average price target has been revised downward by 54.6% in the past 3 months.

→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

Analyst Ratings History

Analyst Ratings Consensus

ChartMill Buy Consensus

76.36%

SURF was analyzed by 11 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about SURF.

In the previous month the buy percentage consensus was at a similar level.

SURF was analyzed by 11 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.

→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Date	Firm	Action	From → To
2023-06-20	Wedbush	Downgrade	Outperform -> Neutral
2023-06-20	Baird	Downgrade	Outperform -> Neutral
2023-06-20	HC Wainwright & Co.	Downgrade	Buy -> Neutral
2023-05-05	HC Wainwright & Co.	Reiterate	Buy
2023-03-10	Wedbush	Reiterate	Outperform
2023-03-10	HC Wainwright & Co.	Reiterate	Buy
2022-11-03	HC Wainwright & Co.	Maintains	Buy
2022-08-08	HC Wainwright & Co.	Maintains	Buy
2021-05-18	BTIG	Initiate	Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date: Oct 31, 2023
Period: Q3 / 2023
EPS Estimate: -$0.36
Revenue Estimate
Revenue Q2Q: N/A
EPS Q2Q: 8.46%
Number of Analysts: 5

Next Earnings Revisions

Revenue (1 Month)

N/A

Revenue (3 Months)

N/A

EPS (1 Month)

1.63%

EPS (3 Months)

-5.42%

Next Earnings Summary

SURF is expected to report earnings on 10/31/2023. The consensus EPS estimate for the next earnings is -0.36 USD and the consensus revenue estimate is 0 USD.

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2023 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

	2020	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030
Revenue YoY % growth	126.2M 719.48%	2.687M -97.87%	30M 1,016.49%	-100.00%		7.945M	25.707M 223.56%	87.958M 242.16%	240.38M 173.29%	349.44M 45.37%	434.37M 24.30%
EBITDA YoY % growth	63.17M 213.59%	-74.444M -217.85%	-60.501M 18.73%	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT YoY % growth	61.5M 207.14%	-76.013M -223.60%	-61.869M 18.61%	-83.744M -35.36%	-92.318M -10.24%	-88.407M 4.24%	-86.873M 1.74%	-44.031M 49.32%	87.084M 297.78%	170.98M 96.34%	235.21M 37.57%
Operating Margin	48.73%	-2,828.92%	-206.23%	N/A	N/A	-1,112.74%	-337.94%	-50.06%	36.23%	48.93%	54.15%
EPS YoY % growth	1.47 174.62%	-1.77 -220.41%	-1.07 39.55%	-1.51 -41.08%	-1.59 -5.41%	-0.86 46.25%	-1.00 -16.48%	-0.74 25.94%	0.73 199.54%	1.20 63.89%	1.58 31.36%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

	Q3 / 23	Q4 / 23	Q1 / 24	Q2 / 24	Q3 / 24	Q4 / 24	Q1 / 25	Q2 / 25	Q3 / 25	Q4 / 25
EPS Q2Q % growth	-0.36 8.46%	-0.36 -2.00%	-0.38 -14.36%	-0.40 13.52%	-0.40 -11.43%	-0.42 -17.14%	-0.21 44.86%	-0.21 46.92%	-0.21 46.41%	-0.20 52.44%
Revenue Q2Q % growth							N/A	N/A	N/A	N/A
EBITDA Q2Q % growth	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Q2Q % growth	-21.551M 5.88%	-21.396M -1.00%	-23.229M -18.14%	-24.101M -7.56%	-24.294M -12.73%	-25.165M -17.62%	N/A	N/A	N/A	N/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year

6.29%

EPS Next 5 Year

5.56%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year

-37.88%

Revenue Next 5 Year

21.55%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year

N/A

EBIT Next 5 Year

N/A

→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

SURFACE ONCOLOGY INC / SURF Forecast FAQ

What do analysts expect the price target to be for SURFACE ONCOLOGY INC (SURF)?

11 analysts have analysed SURF and the average price target is 2.43 USD. This implies a price increase of 127.19% is expected in the next year compared to the current price of 1.07.

What is the next earnings date for SURF stock?

SURFACE ONCOLOGY INC (SURF) will report earnings on 2023-10-31, before the market open.

Can you provide the consensus estimates for SURFACE ONCOLOGY INC next earnings?

The consensus EPS estimate for the next earnings of SURFACE ONCOLOGY INC (SURF) is -0.36 USD and the consensus revenue estimate is 0 USD.

What is the expected long term growth rate for SURF stock?

The expected long term growth rate for SURFACE ONCOLOGY INC (SURF) is -37.88%.

Analyst forecast overview

Forecast Snapshot